vs
Intapp, Inc.（INTA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Intapp, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$140.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 15.7%），Intapp, Inc.自由现金流更多（$22.2M vs $14.4M）
Intapp是一家全球云软件供应商，专注服务律所、会计师事务所、咨询机构、私募股权公司、投资银行等专业服务领域客户，提供客户生命周期管理、风险合规、运营流程自动化、财务绩效管理等相关解决方案，核心市场覆盖北美、欧洲及亚太地区。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
INTA vs PBYI — 直观对比
营收规模更大
INTA
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出12.0%
15.7%
自由现金流更多
INTA
多$7.8M
$14.4M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.2M | $75.5M |
| 净利润 | $-5.9M | — |
| 毛利率 | 75.0% | 69.3% |
| 营业利润率 | -5.1% | 22.7% |
| 净利率 | -4.2% | — |
| 营收同比 | 15.7% | 27.7% |
| 净利润同比 | 41.9% | — |
| 每股收益（稀释后） | $-0.07 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INTAPBYI
| Q4 25 | $140.2M | $75.5M | ||
| Q3 25 | $139.0M | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | — | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润INTAPBYI
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $-14.4M | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率INTAPBYI
| Q4 25 | 75.0% | 69.3% | ||
| Q3 25 | 74.7% | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率INTAPBYI
| Q4 25 | -5.1% | 22.7% | ||
| Q3 25 | -10.4% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率INTAPBYI
| Q4 25 | -4.2% | — | ||
| Q3 25 | -10.3% | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）INTAPBYI
| Q4 25 | $-0.07 | $0.26 | ||
| Q3 25 | $-0.18 | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $191.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $410.2M | $130.3M |
| 总资产 | $795.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资INTAPBYI
| Q4 25 | $191.2M | $97.5M | ||
| Q3 25 | $273.4M | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务INTAPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益INTAPBYI
| Q4 25 | $410.2M | $130.3M | ||
| Q3 25 | $486.4M | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产INTAPBYI
| Q4 25 | $795.2M | $216.3M | ||
| Q3 25 | $823.3M | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | — | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比INTAPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $22.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 15.8% | 19.1% |
| 资本支出强度资本支出/营收 | 0.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流INTAPBYI
| Q4 25 | $22.9M | $14.4M | ||
| Q3 25 | $13.8M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流INTAPBYI
| Q4 25 | $22.2M | $14.4M | ||
| Q3 25 | $13.2M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率INTAPBYI
| Q4 25 | 15.8% | 19.1% | ||
| Q3 25 | 9.5% | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度INTAPBYI
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率INTAPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INTA
| Saa S | $102.5M | 73% |
| License | $25.4M | 18% |
| Professional Services | $12.3M | 9% |
PBYI
暂无分部数据
